GB0916096D0 - A proteolytic product of histone H2A as a marker for cancer - Google Patents

A proteolytic product of histone H2A as a marker for cancer

Info

Publication number
GB0916096D0
GB0916096D0 GBGB0916096.1A GB0916096A GB0916096D0 GB 0916096 D0 GB0916096 D0 GB 0916096D0 GB 0916096 A GB0916096 A GB 0916096A GB 0916096 D0 GB0916096 D0 GB 0916096D0
Authority
GB
United Kingdom
Prior art keywords
histone
marker
cancer
proteolytic product
proteolytic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0916096.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Gent
Original Assignee
Universiteit Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiteit Gent filed Critical Universiteit Gent
Priority to GBGB0916096.1A priority Critical patent/GB0916096D0/en
Publication of GB0916096D0 publication Critical patent/GB0916096D0/en
Priority to PCT/EP2010/063425 priority patent/WO2011029946A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
GBGB0916096.1A 2009-09-14 2009-09-14 A proteolytic product of histone H2A as a marker for cancer Ceased GB0916096D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0916096.1A GB0916096D0 (en) 2009-09-14 2009-09-14 A proteolytic product of histone H2A as a marker for cancer
PCT/EP2010/063425 WO2011029946A1 (en) 2009-09-14 2010-09-14 A proteolytic product of histone h2a as a marker for cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0916096.1A GB0916096D0 (en) 2009-09-14 2009-09-14 A proteolytic product of histone H2A as a marker for cancer

Publications (1)

Publication Number Publication Date
GB0916096D0 true GB0916096D0 (en) 2009-10-28

Family

ID=41277675

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0916096.1A Ceased GB0916096D0 (en) 2009-09-14 2009-09-14 A proteolytic product of histone H2A as a marker for cancer

Country Status (2)

Country Link
GB (1) GB0916096D0 (en)
WO (1) WO2011029946A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103529138B (en) * 2013-07-23 2015-07-08 浙江省疾病预防控制中心 Bovine beta-casein quantitative determination kit and application thereof
JP6813503B2 (en) 2015-02-10 2021-01-13 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング Free histone protein as a biomarker

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009274568A1 (en) * 2008-07-25 2010-01-28 The Regents Of The University Of Colorado Proteins for use in diagnosing and treating infection and disease

Also Published As

Publication number Publication date
WO2011029946A1 (en) 2011-03-17

Similar Documents

Publication Publication Date Title
GB0909904D0 (en) Product
GB0913488D0 (en) Product
GB201001395D0 (en) Product
EP2606130A4 (en) Camkk-beta as a target for treating cancer
EP2451790A4 (en) Histone deacetylase inhibitors
ZA201300004B (en) Cyrstalline form of benzylbenzene sglt2 inhibitor
HUE064419T2 (en) Uses of marker substances
ZA201207839B (en) Pharmaceutical composition comprising a pyrimidineone derivative
BRPI1015368A2 (en) product distributor
IL220936A0 (en) Process for the synthesis of lacosamide
EP2640899A4 (en) Internally illuminated pavement marker
IL226667A (en) Histone inhibition
GB0922589D0 (en) Pharmaceutical compounds
ZA201200888B (en) New tumor marker
SG10201508247PA (en) Wideband signal anlayzer
GB0916978D0 (en) Product
ZA201001972B (en) Novel teteahydrofusedpyridines as histone deacetylase inhibitors
PT2575503E (en) Product comprising catechins
GB0908071D0 (en) Marker
GB0905964D0 (en) Marker
GB0916096D0 (en) A proteolytic product of histone H2A as a marker for cancer
PL2432752T3 (en) Sulphur cement product
GB0908905D0 (en) Pharmaceutical compounds
HU1000081V0 (en) Meat-containing product
GB0917775D0 (en) Novel pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)